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access article under the CC BY-NC-NDSummary Background/Objective: A biphasic ceramic bone substitute consisting of calcium
sulfate and hydroxyapatite has been reported to give good clinical outcome regarding bone
regeneration and may serve as a carrier for antibiotics in the treatment of bone infections.
Often, the overlying muscle is in direct contact with the synthetic graft. The dissolving bone
substitute induces inflammation, which may be harmful to the surrounding soft and muscle tis-
sue. The aim of the present study was to evaluate the surrounding soft tissue reaction and the
biodegradation of the biphasic bone substitute.
Methods: Rods (3 mm 6 mm) were cast and implanted in the rat abdominal rectus muscle. The
rods were either soaked or not soaked in autologous bonemarrow before insertion to induce bone
formation. Thirty-two rats underwent bilateral operation. After 6 weeks and 12 weeks, the bone
substitute material and the surrounding muscle were harvested. The right rod was evaluated by
histology to study tissue reaction and the left rod was analysed with micro-computed tomography
and scanning electron microscopy to study bone substitute degradation.
Results: The muscle tissue around the material was similar at 6 weeks and 12 weeks, with or
without prior treatment with bone marrow. The remaining material showed close contact with
the muscle, and blood vessels penetrated the material in both groups. Wide bundles of collagen
were embedded around the apatite particles, more at the 12-week time point. No bone formation
was found, either at 6 weeks or 12 weeks, and scanning electron microscopy showed that the cal-
cium sulfate phase was resorbed after 6 weeks with the calcium phosphate phase remaining
intact. Micro-computed tomography showed significantlymore hydroxyapatite at 6weeks than af-
ter 12 weeks.s and Biomechanics Laboratory, Department of Orthopaedics, Ska˚ne University Hospital, SE-221 85
med.lu.se (J.-S. Wang).
.11.002
hed by Elsevier (Singapore) Pte Ltd on behalf of Chinese Speaking Orthopaedic Society. This is an open
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Calcium sulfate/apatite biphasic bone substitute 11Conclusion: Calcium sulfate hydroxyapatite bone substitute can beusedas a carrier for antibiotics
or other drugs, without adverse reaction due to the fast resorption of the calcium sulfate. No bone
formation was seen despite treating the bone substitute with autologous bone marrow.
ª 2015 The Authors. Published by Elsevier (Singapore) Pte Ltd on behalf of Chinese Speaking
Orthopaedic Society. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Bone grafts are used to augment and enhance healing in a
number of surgical procedures, for example in bone tumour
resection, eradication in chronic osteomyelitis, nonunion,
revision arthroplasty, and spinal fusions. Due to the well
described limitations of both autografts and allografts [1,2],
synthetic alternatives have been developed over the past 2
decades. An injectable synthetic bone substitute that con-
tains calcium sulfate (CaS) with embedded hydroxyapatite
(HA) has been investigated previously, alone as a void filler in
noncritical defects [3] or as a carrier for antibiotics or other
drugs. It has been shown to promote bone formation, both in
clinical studies and in bone defect animal models [4e9].
However, few studies have focused on the soft tissue reac-
tion. When a bone substitute is used it is often in direct
contact with, or covered by, a muscle. Material leaking from
the filled cavity, or during the resorption of the material
could cause a harmful tissue reaction.
Clinical data have documented that pure CaS pellets can
enhance bone formation in bone defects [10,11]. CaS pellets
seem to function as a conductive scaffold that provides a
structural framework for angiogenesis and osteogenesis
[12,13], but lacks any intrinsic osteoinductive or osteogenic
capacity [14]. The rapid resorption rate of pure CaS is a clear
disadvantage [15,16] that may affect osteoconduction and
cause an inflammatory reaction including short-term
drainage from the wound [17e20]. When CaS is combined
with embedded HA, the resorption of the CaS leaves an
apatite matrix with porosity that encourages bone ingrowth.
Goodman et al [21e24] have tested different materials
as particles and showed that cobalt, chromium, titanium,
and polymer particles as well as polyethylene, all induce an
inflammatory reaction. HA has the ability to promote early
bone growth [25]. It is a biocompatible material with
osteoconductive properties [26,27] but also has the ability
to encourage a host tissue to bond and integrate with an
implant. However, with a bone substitute consisting solely
of loose particles or granules, the particles may migrate
from the implant site before ingrowth of new bone tissue
anchors them in place. Particularly in a joint cavity this may
increase third body wear [28]. By combining HA particles
and calcium sulfate, an injectable material with an initial
containment and stability can be obtained since the cal-
cium sulfate will set within 6e12 minutes and bind the
apatite particles [8].
Based on a limited donor availability but also the
morbidity at the donor site, there will be an increased need
for synthetic bone substitute, either alone or in combina-
tion with allo- and autografts. In several clinical situations,
the bone substitute will come in direct contact with an
overlying muscle and may induce an adverse tissuereaction. It is therefore important to study the reaction of a
synthetic material in the surrounding tissue, especially the
muscles [29], but few studies have focused on the soft
tissue reaction. Bone substitute combined with bone
marrow may have in vivo osteogenic potential. In a sub-
cutaneous implant rat model, bone marrow in combination
with porous HA composites induced bone formation after 4
weeks [30]. In another study, no bone formation was found
using a collagen membrane or bone marrow alone, but bone
formation was observed when the two were combined [31].
The aim of the present study was to evaluate whether
the fast resorption of the CaS phase and the induced
inflammation would negatively influence the histologic
appearance of the surrounding muscle and soft tissue in a
rat rectus abdominal muscle model [32]. Additionally, the




The injectable bone substitute Cerament (Cerament Bone
Void Filler; BoneSupport AB, Lund, Sweden) consists of 60
wt. % CaS and 40 wt. % HA [8,18]. This ratio results in a
mixture with a compressive strength (wet) of 5e8 MPa,
comparable to trabecular bone. The HA particles are
around 5 mm. The HA is of medical grade and tested ac-
cording to American standard (ASTM F1185). The bone
substitute powder was mixed with iohexol (Cerament C-
TRU; 180 mg I/mL), a low osmolar nonionic iodinated
contrast agent to form an injectable paste. The ratio of
liquid to powder was 0.43. The Cerament was mixed for 30
seconds and then injected into a sterilised Teflon mould
with holes that were 3 mm in diameter and 6 mm deep.
After 12 hours, the cement was cured and the rods removed
and stored in a sterilised glass bottle prior to implantation.
Animals and implantation
A total of 32 female SpragueeDawley rats with body weight
of 190e220 g (age 8 weeks) were operated on. Rats were
obtained from Taconic (Ry, Denmark). The rats were housed
in a temperature-controlled room (21C) and fed a standard
laboratory diet. Three rats were kept in each cage with free
access to food pellets and water. All animal procedures were
carried out according to the institutional guidelines and
were approved by the Ethic Animal Research Committee
(M45-09) at Ska˚ne University Hospital, Lund, Sweden.
The experiment was divided into two groups. In Group 1,
16 ratswere implantedwithapair ofCerament rods. InGroup
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Cerament rods. Bone marrow was taken from the femoral
condyle by making a small incision in the lateral femoral
condyle using an 18-gauge needle and a 5-mL syringe. The
femoral wound was closed with sutures. Two rods were
placed in aPetri dish, and thebonemarrowwas injectedonto
the rods and left to soak for 10minutes prior to implantation.
The rats were anaesthetised by 0.4 mL of a mixture con-
taining 1 mL pentobarbital, 1 ml saline solution and 10 mg/
2 mL diazepam. Antibiotics were given (0.5 mL Streptocillin)
before the operation. A 10 mm incision was made in the mid
line of the abdomen. A muscle pouch (4 mm wide and 8 mm
long) was created between the abdominal muscles and then
two rods were implanted in each rat, one rod in the left
pouch and one rod in the right pouch (Figure 1). The pouches
were closed by sutures aswas the skinwound. Eight rats from
each treatment groupwere harvested at 6weeks or 12weeks
after implantation, respectively. One rod from the right side
of each animal was taken for histology analysis and the other
rod from the left side of the same animal was used for micro-
computed tomography (CT) and scanning electron micro-
scope (SEM) analysis.
Histology
The ceramic rod from the right side of each rat with sur-
rounding muscles was harvested and fixed in 4% formalin in
buffer, before being decalcified, dehydrated, and
embedded in paraffin. The specimens were cut into 5-mm
sections and stained with haematoxylin and eosin. The
tissue reaction to the material was analysed using optical
microscopy by observing inflammatory cells, tissue
ingrowth and bone-like tissue in and around the materials.
Micro-CT
The ceramic rod from the left side of each rat was fixed in
70% ethanol. The harvested samples were analysed usingFigure 1 A ceramic rod inserted into a rat abdominal muscle
pouch. One incision was used and one Cerament rod was placed
on the left side and the other on the right side of the rectus
muscle. We implanted two rods in each animal, one for his-
tology and one for micro-computed tomography and scanning
electron microscope analysis.micro-CT. Topographic images of the sample was acquired
with an isotropic voxel size of 15mm (Skyscan 1172; Bruker
Microct, Aartselaar, Belgium) at the energy settings of
100 kV and 100 mA, using a 0.5-mm aluminium filter, and 10
repeated scans. Image reconstruction was performed
(Skyscan NRecon, version 1.5.1.4; Bruker Microct) by cor-
recting for ring artefacts and beam hardening (20%). Cali-
bration of bone mineral density was carried out according
to the system manufacturer’s protocol. A water phantom
and two HA phantoms of known densities (0.25 g/cm3 and
0.75 g/cm3) were scanned. To distinguish the remaining
fully mineralised tissue, a threshold of 0.6 g/cm3 [33] was
used, where the mineralised material was all tissue with a
density higher than the threshold. This resulted in greyscale
values > 90 (90e255 in 8 bit images) for mineralised ma-
terial. A quantification of the remaining mineralised ma-
terial from each specimen at 6 weeks and 12 weeks was
performed using custom made Matlab scripts (Matlab, v
7.11.0, MathWorks Inc., Natick, USA). Two nonimplanted
rods were imaged with the same settings and used as con-
trols. Thus, the mineralised remaining material was nor-
malised to the mineralised volume of the intact rods. Data
were analysed by Student t test.SEM and energy-dispersive X-ray spectroscopy
One specimen from each treatment and each time point,
and one nonimplanted specimen were examined using an
SEM equipped with an energy-dispersive X-ray spectroscopy
(EDS) system (JSM-6700F; Jeol, Tokyo, Japan). The electron
beam energy was 15 kV and the acquisition time 100 sec-
onds. The samples were obtained after micro-CT exami-
nation and were dehydrated with ethanol and cut through
the material and muscles with an IsoMet Low Speed Dia-
mond Saw (Buehler, Lake Bluff, IL, USA). The samples were
coated with carbon in order to identify and evaluate the
relative concentrations of chemical elements present in the
tissues [34]. The morphology and structure of the tissue
integration were analysed. Material elemental analysis with
the EDS was performed with interest points in the remain-
ing material clusters and in the tissue. Two different re-
gions of interest were chosen for chemical analysis, one in
the remaining material cluster and one containing tissue
integrated material. The area of interest was defined with
500 image and a region of approximately 5690 mm2 was
used for element analysis in each specimen. The analysed
elements included O, P, S, Cl, and Ca [35].Results
Histology
In the histological samples, there was more remaining
material after 6 weeks compared to after 12 weeks. Most of
the remaining material consisted of many small aggregated
particles around 5 mm in diameter. The material had been
invaded by fibrous tissue. Signs of a minor inflammatory
reaction were found around the material clusters and, in
some sections, giant cells or multinuclear cells were
attached to the clusters.
Figure 3 Collagen (black arrows) in close contact with
Cerament (double-headed arrows) without bone marrow
treatment at (A) 6 weeks and (B) 12 weeks (haematoxylin and
eosin staining, magnification, 20).
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the bone substitute was in close contact with the muscle,
and muscle fibres penetrated into the material (Figure 2).
No muscle necrosis was observed and the formation of
granulation tissue was low. A rich network of blood vessels
penetrated the material in all groups, i.e., both samples
with or without bone marrow treatment, and both after 6
weeks and 12 weeks (Figure 2).
Neither osteoid nor osteoblasts could be found in any
specimen. Instead, wide bundles of collagen had formed in
the material. More collagen was found around the
remaining material clusters after 12 weeks compared to 6
weeks, but no difference was seen when comparing speci-
mens with or without bone marrow treatment (Figure 3).
Micro-CT
Micro-CT detected clusters of mineral particles within the
softer tissue (Figure 4). The remaining mineralised volume
was significantly higher after 6 weeks than after 12 weeks
(p < 0.001, t test; Figure 5). Also, the mineralised surface
was significantly higher after 6 weeks than after 12 weeks
(p < 0.001, t test; Figure 5). No statistical differences were
observed when comparing samples with or without bone
marrow treatment at either time point. Thus, different
parts of the material were resorbed during the different
time periods (Figure 5).
SEM and EDS
The SEM images and EDS of the intact pellet that had not
been implanted showed that both CaS and HA particles
were present in the Cerament (Figure 6). The element
analysis of the intact Cerament had not been implanted
showed a strong sulfur peak of 9.2%. The remaining ele-
ments were distributed according to Table 1. SEM obser-
vations of the samples implanted in the muscle pouch
showed that after 6 weeks the Cerament rod had separatedFigure 2 The interface between the Cerament andmuscle (haema
marrow at 6 weeks; (B) with bonemarrow at 6 weeks; (C) without bon
close contact can be seen between the remainingmaterial andmuscl
blood vessels (yellow arrows) has penetrated the material, both theinto small clusters and were surrounded by ingrown tissue
(Figure 7). After 12 weeks, the clusters were fewer in
number and also smaller. The amount, size, and shape of
the material particles were similar to those observed after
6 weeks. Based on EDS analysis after both 6 weeks and 12
weeks, no sulfur, and thus no sulfate, was found in the
material clusters (Table 1). However, a small amount of
sulfur was detected at the tissue surrounding the material
particles after both 6 weeks and 12 weeks. All other ele-
ments, as well as the Ca/P ratio were similar both after 6
weeks and 12 weeks.toxylin and eosin staining,magnification,20). (A)Without bone
emarrow at 12 weeks; and (D) with bonemarrow at 12 weeks. A
e (black arrows). At both 6weeks and 12weeks, a rich network of
marrow-treated and non-marrow-treated material.
Figure 4 Micro-computed tomography showing the remaining Cerament in the harvested muscle and soft tissue. The area be-
tween the material clusters is penetrated by cells and collagen which can be seen in the histology panels (see Figure 3).
Figure 5 Micro-computed tomography evaluation of remaining mineralised volume after 6 weeks and 12 weeks in the Cerament
(C) and the Cerament treated with bone marrow (CþBM). (A) The remaining mineralised volume was normalised to the intact pellet
volume. The (B) surface of the remaining mineralised material was normalised to the surface of the intact rods. Significant dif-
ferences are based on Student t test (p < 0.001).
Figure 6 Scanning electron microscopy shows mixed calcium
sulfate with long rod shape (white arrows) and hydroxyapatite
particles with round shape (yellow arrows) in Cerament that
had not been implanted. Energy-dispersive X-ray spectroscopy
was performed with the areas of arrow points in the material.
Table 1 Percentage of elements in the specimens from
the intact Cerament rod (control) and after 6 weeks and 12
weeks by energy-dispersive X-ray spectroscopy analysis.
Specimens Iron in Cerament/
surrounding tissue
Weight (%)
O P S Cl Ca
Control Cerament 72.6 3.7 9.2 0.4 13.6
6-wk C Cerament 63.9 13.5 0.0 0.3 21.5
Tissue 77.2 4.1 0.5 11.9 6.4
6-wk CþBM Cerament 63.8 14.8 0.0 0.4 20.2
Tissue 66.6 10.2 0.6 7.8 14.7
12-wk C Cerament 65.5 12.1 0.0 0.5 21.2
Tissue 79.0 4.2 0.6 10.9 5.2
12-wk CþBM Cerament 62.5 11.9 0.0 3.6 21.7
Tissue 75.0 4.3 0.7 13.5 6.3
Data are presented as the mean of two measurements.
BM Z bone marrow; C Z Cerament.
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A benign muscle tissue reaction was found around the
material, similar at 6 weeks and 12 weeks, and regardless
of prior treatment with bone marrow. The remainingmaterial showed close contact with the muscle, and blood
vessels penetrated the material in both groups. Wide bun-
dles of collagen were embedded around the apatite parti-
cles, in particular at the 12-week time point, in both with
or without prior treatment with bone marrow. No bone
formation was found in the muscles pouch at 6 weeks or 12
weeks. SEM showed that the CaS was resorbed after 6
Figure 7 Scanning electron microscope pictures show the remaining material cluster or particles (yellow arrows) in the tissue
(white arrows). (A) The sample from 6 weeks; (B) particles of the material from the middle part of the material cluster of (A). (C)
The sample from 12 weeks; and (D) particles of the material from the middle of the material cluster in (C). Energy-dispersive X-ray
spectroscopy was performed with the arrow points in the remaining material clusters and tissue.
Calcium sulfate/apatite biphasic bone substitute 15weeks, and micro-CT showed that the HA was slowly
resorbing between 6 weeks and 12 weeks.
A biphasic in situ setting bone substitute containing CaS
and HA has been clinically studied with good outcome, and
used both in osteotomies, vertebral bodies, long bones,
fracture surgery, and for augmenting cannulated screws
[8]. It has also been used in animal defect models showing
good biocompatibility and osteoconductivity [4,5]. We have
previously shown good tissue integration and bone ingrowth
in a fully loaded joint implant in a rat model using a non-
cemented tibial prosthesis, treated with the CaS/HA ma-
terial [9]. Previous studies also demonstrated an increased
pull-out strength at 12 weeks in the treated group. Clinical
studies have shown good long-term results using a combi-
nation of HA particles in combination with allograft in ac-
etabulum [36]. In an earlier study, we were able to show
good soft tissue and muscle integrations with a preset of
calcium phosphate with CaS material when implanted in
the rat muscle pouch model [37]. However, when a bone
substitute is used it is often in direct contact with or
covered by a muscle and sometimes aspirated bone marrow
is added or leaking out from the resected bone area. These
types of tissue can give a more severe and different tissue
response compared to when using a bone substitute in a
contained bone defect. The reports of adverse reactions to
surgical-grade CaS used as bone grafting in patients with a
so called white drainage were essentially self-limited and
appeared benign [20]. However, it may lead to a local in-
flammatory process at the implantation site. Similarly, a
slow-setting calcium phosphate has been shown to evokesignificant inflammatory reaction [34]. Large vesicles con-
taining inflammatory effusion formed around a calcium
phosphate cement, consisting of an equimolar mixture of
tetracalcium phosphate and dicalcium phosphate anhy-
drous (DCPA). A more rapidly setting calcium phosphate was
covered with a layer of granulation tissue and presented an
inflammatory cell reaction but did not give any effusion.
The analyses in these studies were all carried out in a rat
model at 1 week after surgery [35]. Interestingly, DCPA was
always found in the slow-setting phosphate cement. How-
ever, there was also a small amount of inert DCPA present 1
week after implantation in the fast-setting cement. The
absence of similar tissue reactions in our study may be due
to the small volume of CaS used and that the HA particles
might act as a barrier, retarding the calcium sulfate
resorption [8].
In our study, adding bone marrow to the bone substitute
rods did not show any effect on the tissue integration and
biocompatibility in the soft tissue. A difference between
our and previous studies using calcium phosphate cement,
is that the material was injected directly into a subcu-
taneous pouch in the rat abdominal muscle, whereas we
used rods that were already pretreated. However, we find
it unlikely that this would influence the result, since our
CaS/apatite material had a fast setting time of 12 minutes,
comparable to the fast-setting phosphate cement in the
study reported by Miyamoto et al [35]. We observed a rich
network of vessels that had infiltrated the material and,
further, thick bundles of collagen around the remaining HA
particles at both time points. However, no bone formation
16 J.-S. Wang et al.was at neither 6 weeks nor 12 weeks. Additionally, from the
SEM and EDS, it was clear that there were minimal amounts
of sulfate in the remaining material already at 6 weeks. A
limitation of the study was that we did not perform
immunohistochemistry analysis. This could give more in-
formation of the tissue reaction. Furthermore, it is still
unclear how the immunological response will be for the
specific model compared to humans, but we still believe
that these results provide important information and in-
dications for further studies.
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